Surgical site infections (SSIs) are wound infections that occur after invasive surgical procedures. Depending on the location of the wound and the level of post-operative care that the patient receives, the risk of developing an SSI can be as high as 20%,1 although across all patients undergoing inpatient procedures in the United States, the rate of SSI occurrence is between 2% and 4%.2 SSI represents one of the major causes of post-operative morbidity and mortality and frequently contributes to extended hospital stays.3 In many instances, SSIs result from cross-contamination, or the transfer of harmful microorganisms, during the procedure itself or when follow-up wound care is administered. Infections secondary to cross-contamination are usually caused by bacteria, fungi, parasites, or viruses.4
Cross-contamination of microorganisms post-operatively can occur in many ways, including4:i
The dangers of an SSI that resulted from cross-contamination vary depending on patient comorbidities; however, these infections are the second most common forms of nosocomial infections accounting for an increased risk of death.5 Even in cases where the patient is not at risk for mortality, post-operative cross-contamination can complicate and prolong the healing process, increase patient pain and discomfort, delay discharge from the hospital, and significantly increase medical costs for the patient.
There are substantial benefits—both for the patient and for the health care system—in preventing cross-contamination in surgical wounds whenever possible. Strategies for successfully preventing post-operative cross-contamination include:
Infection prevention cannot be achieved in every single instance; however, proper preventative techniques can greatly reduce the number of post-operative patients who develop SSIs. When adhered to, these measures can improve the healing environment for patients and can often lead to better patient outcomes after surgical procedures and reductions in the overall cost of post-operative care.
References
1. Pawlowska I, Ziolkowski G, Wojkowska-Mach J, Bielecki T. Can surgical site infections be controlled through microbiological surveillance? A three-year laboratory-based surveillance at an orthopedic unit, retrospective observatory study. Int Orthop. 2019;43(9):2009-2016.
2. Mana TSC, Donskey C, Carty N, Perry L, Leaper D, Edmiston CD Jr. Preliminary analysis of the antimicrobial activity of a postoperative wound dressing containing chlorhexidine gluconate against methicillin-resistant Staphylococcus aureus in an in vivo porcine incision wound model. Am J Infect Control. 2019;47:1048-1052.
3. Hussain A, Amna A, Brohi S, Nadeem F, et al. Frequency of post-operative wound contamination in Bakhtawar General Hospital, Jamshoro. J Islamabad Med Dent Coll. 2020;9(1):54-58.
4. Cherney K. Cross infection. Healthline. 2017. https://www.healthline.com/health/cross-infection. Accessed September 10, 2020.
5. Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478-482.
6. Nazarko L. Good hygiene when dressing wounds. Nursing in Practice. 2016. https://www.nursinginpractice.com/clinical/good-hygiene-when-dressing-w…. Accessed September 10, 2020.
7. Webster J, Larsen E, Marsh N, Choudhury A, Harris P, Rickard CM. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of a central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial). J Hosp Infect. 2017;96(3):223-228.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.